Hormone Therapy

Editor's Choice

Hormone Therapy and Breast Cancer Precursor Link Studied

A decline in the use of postmenopausal hormone treatment in the past decade may be a factor in the decreased incidence of atypical ductal hyperplasia, a suspected precursor of some breast cancers, according to a study in the November issue of Cancer Epidemiology, Biomarkers & Prevention.

LATEST ARTICLES

Gain knowledge from NAMS on life after hormone therapy

The following Q & A article summarizes a discussion in Menopause e-Consult, a newsletter of the North American Menopause Society (NAMS).

Hormonal contraceptives: Do patients understand the real benefits and risks?

Misconceptions about oral contraceptives, the vaginal ring, and the transdermal patch can deprive patients of their full benefits.

Hormone Therapy May Increase Ovarian Cancer Risk

Findings from a cohort study suggest that hormone therapy increases a woman's risk of ovarian cancer, regardless of the duration of use, dose, formulation, or route of administration, researchers said recently. Complete this CME to learn more.

Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care

Somatic symptoms are the primary reason that individuals seek medical care; complaints of pain account for about half of these visits. Up to 75% of pain has no identifiable physical cause, and maladaptive pain negatively affects every aspect of patients? lives.

New Horizons in the Management of Type 2 Diabetes: Expanding the Treatment Paradigm for Glycemic Control and Risk Reduction

This activity will review the pathogenesis of type 2 diabetes, the mechanisms by which incretin hormones affect glucose homeostasis, the impact of early intervention on glycemic control, and the role of incretin-based therapeutics in the management of type 2 diabetes.